Structures by: Michael J. P.
Total: 60
C14H13N3O
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=13.488(2)Å b=9.6611(15)Å c=9.3604(13)Å
α=90° β=90.183(5)° γ=90°
C14H13N3O
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=25.8998(13)Å b=5.5463(3)Å c=8.3187(4)Å
α=90° β=95.876(4)° γ=90°
C14H13N3O
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=10.2114(2)Å b=30.3315(7)Å c=8.2353(2)Å
α=90° β=110.1930(10)° γ=90°
C14H13N3O
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=6.3542(4)Å b=7.6624(6)Å c=49.231(3)Å
α=90° β=90° γ=90°
Isonicotinic acid-(1-phenyl-ethylidenehydrazide)
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=10.6217(16)Å b=14.442(2)Å c=8.2589(12)Å
α=90° β=109.623(5)° γ=90°
C14H13N3O
C14H13N3O
CrystEngComm (2015) 17, 28 5143
a=9.7360(6)Å b=9.8752(6)Å c=26.1543(16)Å
α=92.856(4)° β=100.295(4)° γ=91.291(4)°
C21H21ClN2O7S
C21H21ClN2O7S
Organic letters (2004) 6, 2 293-296
a=7.728(4)Å b=10.467(5)Å c=15.821(8)Å
α=101.849(9)° β=94.878(10)° γ=108.820(9)°
C24H18O2
C24H18O2
Organic & Biomolecular Chemistry (2004) 2, 23 3504-3509
a=7.7959(9)Å b=20.639(3)Å c=11.0953(14)Å
α=90.00° β=90.00° γ=90.00°
1-(2-Fluorophenyl)cyclohexanecarbocamide
C13H16FNO
CrystEngComm (2008) 10, 1 95
a=11.792(5)Å b=8.646(4)Å c=12.170(5)Å
α=90° β=111.510(7)° γ=90°
1-Phenylcyclopentanecarboxamide
C12H15NO
CrystEngComm (2008) 10, 1 95
a=14.140(2)Å b=7.3843(11)Å c=10.2066(15)Å
α=90° β=109.291(10)° γ=90°
1-Phenylcyclohexanecarboxamide
C13H17NO
CrystEngComm (2008) 10, 1 95
a=13.8232(19)Å b=6.1326(8)Å c=26.176(4)Å
α=90° β=90° γ=90°
1-(2-Chlorophenyl)cyclohexanecarboxamide
C13H16ClNO
CrystEngComm (2008) 10, 1 95
a=13.314(2)Å b=9.3311(13)Å c=29.104(4)Å
α=90° β=90.109(10)° γ=90°
1-(2-Bromophenyl)cyclohexanecarboxamide
C13H16BrNO
CrystEngComm (2008) 10, 1 95
a=8.9257(13)Å b=10.8387(16)Å c=13.7825(19)Å
α=69.877(10)° β=87.223(11)° γ=82.095(11)°
Meso-3,3'-dioxo-6,7,6',7'-tetrahydro- 5H,5H'-[2,2']bi([1,3]thiazolo[3,2-a]pyridinyl)-2,2',8,8'-tetracarboxylate
C26H32N2O10S2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 17 2055
a=9.1807(19)Å b=11.696(2)Å c=13.880(3)Å
α=90.00° β=105.103(4)° γ=90.00°
Theophylline--3,4-dihydroxybenzoic acid (1/1)
C7H8N4O2,C7H6O4
Acta Crystallographica Section C (2018) 74, 6
a=6.7095(3)Å b=13.7764(6)Å c=30.7205(15)Å
α=90° β=90° γ=90°
1-(2-Pyridyl)pyrrolidine-2-thione
C9H10N2S
Acta Crystallographica Section E (2004) 60, 12 o2298-o2300
a=6.8504(8)Å b=7.3247(9)Å c=9.5740(11)Å
α=87.965(2)° β=85.299(2)° γ=64.705(2)°
(1R,2R)-Ethyl 1-azido-2-hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indole-9-carboxylate
C14H14N4O3
Acta Crystallographica Section E (2005) 61, 2 o269-o271
a=5.8464(9)Å b=8.8422(14)Å c=26.927(4)Å
α=90.00° β=90.00° γ=90.00°
6,8-Dimethoxy-1,3-trans-dimethylisochroman-5-yl diethyl phosphate
C17H27O7P
Acta Crystallographica Section E (2002) 58, 4 o440-o441
a=19.7987(11)Å b=11.2320(5)Å c=19.3329(11)Å
α=90.00° β=115.880(2)° γ=90.00°
1-[3,5-Bis(bromomethyl)-2,4,6-trimethoxybenzyl]-3,5-bis(bromomethyl)-2,4,6- trimethoxybenzene
C23H28Br4O6
Acta Crystallographica Section E (2006) 62, 1 o168-o170
a=22.737(7)Å b=7.280(2)Å c=15.280(4)Å
α=90.00° β=90.00° γ=90.00°
5,8-Dimethoxy-3-methyl-1H-isochroman
C12H16O3
Acta Crystallographica Section E (2003) 59, 7 o992-o993
a=13.2543(15)Å b=5.9923(7)Å c=14.5744(17)Å
α=90.00° β=101.633(2)° γ=90.00°
C8H13NO3
C8H13NO3
Acta Crystallographica Section C (1991) 47, 12 2680-2682
a=27.89(2)Å b=6.327(2)Å c=22.040(10)Å
α=90° β=114.65(4)° γ=90°
(2E)-2-(1-Methylpiperidin-2-ylidene)-1-phenylethanone
C14H17NO
Acta Crystallographica Section E (2007) 63, 1 o98-o99
a=8.006(2)Å b=9.441(3)Å c=15.535(4)Å
α=90° β=95.197(6)° γ=90°
Β-Amyrin benzoate
C37H54O2
Acta Crystallographica Section E (2007) 63, 6 o3032-o3033
a=6.78970(10)Å b=12.0370(2)Å c=37.8246(6)Å
α=90° β=90° γ=90°
Ethyl (2E)-[1-(4-methoxyphenyl)pyrrolidin-2-ylidene]acetate
C15H19NO3
Acta Crystallographica Section E (2007) 63, 7 o3139-o3140
a=9.7056(4)Å b=9.7763(3)Å c=15.0413(5)Å
α=93.126(2)° β=92.987(2)° γ=103.301(2)°
1-(p-Tolylsulfonyl)propan-2-one
C10H12O3S
Acta Crystallographica Section E (2006) 62, 12 o5630-o5631
a=14.5381(16)Å b=5.5394(6)Å c=14.6879(16)Å
α=90° β=114.998(2)° γ=90°
1-(2-Chlorophenyl)cyclohexanecarbonitrile
C13H14ClN
Acta Crystallographica Section E (2007) 63, 2 o916-o917
a=7.7680(5)Å b=11.9121(9)Å c=12.9065(8)Å
α=90° β=107.129(4)° γ=90°
1-(2-Bromophenyl)cyclohexanecarbonitrile
C13H14BrN
Acta Crystallographica Section E (2007) 63, 2 o918-o919
a=7.8650(9)Å b=11.7892(14)Å c=13.1101(13)Å
α=90° β=106.531(5)° γ=90°
Ethyl (2E)-3-oxo-2-(pyrrolidin-2-ylidene)butanoate
C10H15NO3
Acta Crystallographica Section E (2007) 63, 5 o2380-o2382
a=7.5637(3)Å b=5.2527(3)Å c=25.4713(13)Å
α=90.00° β=97.554(3)° γ=90.00°
Cyclohexanecarboxamide
C7H13NO
Acta Crystallographica Section C (2009) 65, 11 o553-o554
a=24.624(3)Å b=6.6934(9)Å c=9.4030(13)Å
α=90.00° β=102.088(3)° γ=90.00°
2-{[(4-Methylphenyl)sulfonyl]amino}phenyl 4-methylbenzenesulfonate
C20H19NO5S2
Acta Crystallographica Section C (2007) 63, 5 o309-o311
a=9.7596(2)Å b=10.1025(2)Å c=10.7227(2)Å
α=80.1730(10)° β=76.6330(10)° γ=71.4420(10)°
(2Z)-1-(4-Bromophenyl)-2-(pyrrolidin-2-ylidene)ethanone
C12H12BrNO
Acta Crystallographica Section C (2007) 63, 12 o734-o738
a=5.6636(3)Å b=18.9255(9)Å c=10.0500(5)Å
α=90.00° β=94.1360(10)° γ=90.00°
(2Z)-1-(4-Bromophenyl)-2-(piperidin-2-ylidene)ethanone
C13H14BrNO
Acta Crystallographica Section C (2007) 63, 12 o734-o738
a=6.9303(2)Å b=7.6280(2)Å c=12.1060(3)Å
α=99.844(2)° β=99.5450(10)° γ=102.189(2)°
(2Z)-2-(Azepan-2-ylidene)-1-(4-bromophenyl)ethanone
C14H16BrNO
Acta Crystallographica Section C (2007) 63, 12 o734-o738
a=12.2867(3)Å b=8.2416(2)Å c=12.9404(4)Å
α=90.00° β=100.702(2)° γ=90.00°
(+-)-3-<i>exo</i>,6-<i>exo</i>-dibromo-5-<i>endo</i>-hydroxy-3-<i>endo</i>- nitrobicyclo[2.2.1]heptane-2-<i>exo</i>-carbonitrile
C8H8Br2N2O3
Acta Crystallographica Section C (2011) 67, 8 o288-o293
a=6.6517(8)Å b=16.084(2)Å c=9.8254(14)Å
α=90° β=91.825(6)° γ=90°
(+-)-3-<i>exo</i>,6-<i>exo</i>-dibromo-6-<i>endo</i>-nitro-5-<i>exo</i>- phenylbicyclo[2.2.1]heptan-2-<i>endo</i>-ol
C13H13Br2NO3
Acta Crystallographica Section C (2011) 67, 8 o288-o293
a=15.945(2)Å b=6.7578(10)Å c=13.194(2)Å
α=90° β=107.655(9)° γ=90°
(+-)-methyl 3-<i>exo</i>,6-<i>exo</i>-dibromo-5-<i>endo</i>-hydroxy-3-<i>endo</i>- nitrobicyclo[2.2.1]heptane-2-<i>exo</i>-carboxylate
C9H11Br2NO5
Acta Crystallographica Section C (2011) 67, 8 o288-o293
a=6.7221(2)Å b=7.7353(3)Å c=12.1546(5)Å
α=88.296(3)° β=80.595(3)° γ=69.323(3)°
(+-)-methyl 3-<i>exo</i>,6-<i>exo</i>-dibromo-7-(diphenylmethylidene)-5-<i>endo</i>- hydroxy-3-<i>endo</i>-nitrobicyclo[2.2.1]heptane-2-<i>exo</i>-carboxylate
C22H19Br2NO5
Acta Crystallographica Section C (2011) 67, 8 o288-o293
a=15.8724(8)Å b=9.0341(4)Å c=15.0064(7)Å
α=90° β=98.219(2)° γ=90°
(+-)-methyl 3-<i>exo</i>,6-<i>exo</i>-dibromo-5-<i>endo</i>-hydroxy-3-<i>endo</i>-nitro- 7-oxabicyclo[2.2.1]heptane-2-<i>exo</i>-carboxylate
C8H9Br2NO6
Acta Crystallographica Section C (2011) 67, 8 o288-o293
a=7.8071(13)Å b=22.760(4)Å c=6.7673(10)Å
α=90° β=110.320(10)° γ=90°
<i>rac</i>-(<i>rel</i>-1<i>R</i>,2<i>R</i>,4<i>S</i>)- Spiro[bicyclo[2.2.1]heptane-2,3'-indol]-2'-amine
C14H16N2
Acta Crystallographica Section E (2011) 67, 2 o394
a=19.2145(14)Å b=11.3371(8)Å c=10.3399(7)Å
α=90° β=90° γ=90°
2-[(2<i>Z</i>)-Azepan-2-ylidene]-1-(4-nitrophenyl)ethanone
C14H16N2O3
Acta Crystallographica Section E (2012) 68, 8 o2479
a=6.7963(3)Å b=8.4054(3)Å c=11.6649(5)Å
α=76.508(2)° β=81.134(2)° γ=80.596(2)°
3-Hydroxy-1-(4-methoxybenzyl)piperidin-2-one
C13H17NO3
Acta Crystallographica Section E (2013) 69, 1 o51
a=12.980(3)Å b=7.6143(17)Å c=12.189(3)Å
α=90.00° β=90.497(5)° γ=90.00°
(+-)-3-Benzyloxy-1-(4-methoxybenzyl)piperidine-2-thione
C20H23NO2S
Acta Crystallographica Section E (2013) 69, 1 o21
a=18.371(3)Å b=10.4844(15)Å c=18.467(3)Å
α=90.00° β=90.00° γ=90.00°
1-(2-Hydroxy-4,5-dimethoxyphenyl)ethanone
C10H12O4
Acta Crystallographica Section E (2013) 69, 1 o139
a=19.1740(12)Å b=5.5026(3)Å c=8.9956(5)Å
α=90.00° β=90.00° γ=90.00°
(2-Aminophenyl)methanol
C7H9NO
Acta Crystallographica Section E (2012) 68, 1 o174
a=22.6222(9)Å b=6.0675(2)Å c=4.7005(2)Å
α=90.00° β=90.00° γ=90.00°
4-(Dimethoxymethyl)phenyl 2,3,4,6-tetra-<i>O</i>-acetyl-β-<i>D</i>-glucopyranoside
C23H30O12
Acta Crystallographica Section E (2012) 68, 4 o1202
a=7.9004(2)Å b=10.9961(3)Å c=29.2289(8)Å
α=90.00° β=90.00° γ=90.00°
(+-)-(<i>rel</i>-3<i>R</i>,3'<i>R</i>)-1,1'-Dimethyl-3,3'-bipyrrolidine-2,2'- dithione
C10H16N2S2
Acta Crystallographica Section E (2012) 68, 11 o3211
a=20.520(3)Å b=5.7237(7)Å c=11.220(2)Å
α=90° β=122.009(5)° γ=90°
2,3-Dihydro-1<i>H</i>-pyrrolo[1,2-<i>a</i>]indole-9-carbonitrile
C12H10N2
Acta Crystallographica Section E (2012) 68, 12 o3306
a=9.1383(3)Å b=9.5340(3)Å c=12.3138(4)Å
α=90.794(2)° β=90.528(2)° γ=116.272(2)°
(2<i>E</i>)-1-Phenyl-2-[1-(2-phenylprop-2-en-1-yl)pyrrolidin-2-ylidene]ethanone
C21H21NO
Acta Crystallographica Section E (2012) 68, 12 o3281
a=5.7806(6)Å b=7.9407(7)Å c=9.6089(9)Å
α=82.579(7)° β=76.793(7)° γ=83.510(7)°
C14H13NO2
C14H13NO2
Crystal Growth & Design (2011) 11, 5 1431
a=5.1936(6)Å b=13.2328(14)Å c=17.0316(17)Å
α=90.00° β=90.125(4)° γ=90.00°
C14H11NO2
C14H11NO2
Crystal Growth & Design (2013) 13, 8 3463
a=4.55320(10)Å b=15.0996(4)Å c=16.1510(5)Å
α=90.00° β=96.515(2)° γ=90.00°
C18H15N3O2
C18H15N3O2
Crystal Growth & Design (2013) 13, 8 3463
a=30.2956(11)Å b=8.2672(3)Å c=26.5597(9)Å
α=90.00° β=117.346(2)° γ=90.00°
C21H17NO3
C21H17NO3
Crystal Growth & Design (2013) 13, 8 3463
a=5.9682(3)Å b=12.0166(6)Å c=22.9633(12)Å
α=90.00° β=90.091(4)° γ=90.00°
C14H11NO2
C14H11NO2
Crystal Growth & Design (2013) 13, 8 3463
a=3.89490(10)Å b=25.1426(8)Å c=16.8477(5)Å
α=90.00° β=95.522(2)° γ=90.00°
C18H15N3O2
C18H15N3O2
Crystal Growth & Design (2013) 13, 8 3463
a=8.2469(2)Å b=8.2333(2)Å c=22.0039(5)Å
α=90.00° β=95.544(2)° γ=90.00°
C21H17NO3
C21H17NO3
Crystal Growth & Design (2013) 13, 8 3463
a=8.7529(4)Å b=9.5545(4)Å c=39.9926(17)Å
α=90.00° β=90.00° γ=90.00°
C18H17N3O2
C18H17N3O2
Crystal Growth & Design (2013) 13, 8 3463
a=4.2509(7)Å b=11.363(3)Å c=31.115(6)Å
α=90.00° β=90.00° γ=90.00°
C23H19Cl2NO3
C23H19Cl2NO3
Inorganic chemistry (2014) 53, 9 4418-4429
a=38.968(4)Å b=46.919(5)Å c=4.3266(3)Å
α=90.00° β=90.00° γ=90.00°
C15H14ClNO2
C15H14ClNO2
Inorganic chemistry (2014) 53, 9 4418-4429
a=4.1955(2)Å b=26.0540(15)Å c=12.1996(8)Å
α=90.00° β=90.279(2)° γ=90.00°
C14H13NO2
C14H13NO2
Crystal Growth & Design (2011) 11, 5 1431
a=12.5115(4)Å b=7.3273(2)Å c=12.6648(4)Å
α=90.00° β=100.052(2)° γ=90.00°
C18H17N3O2
C18H17N3O2
Crystal Growth & Design (2013) 13, 8 3463
a=13.4793(8)Å b=6.6293(4)Å c=18.5481(12)Å
α=90.00° β=108.540(2)° γ=90.00°